金融部門


負債 変化する 日付
Adma Biologics USD 203.84M 567K 2026-06
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
Eli Lilly USD 54.91B 11.54B 2026-06
Halozyme Therapeutics USD 2.15B 2.02M 2026-06
Insmed USD 544.86M 180.93M 2026-09
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
MacroGenics USD 35.09M 1.42M 2026-06
MannKind USD 330.85M 112K 2026-06
Merck USD 53.91B 4.79B 2026-06
Minerva Neurosciences USD 0 0 2024-09
Novavax USD 233.31M 4.23M 2024-09
Novo Nordisk DKK 146.38B 27.66B 2026-03
Pfizer USD 62.67B 523M 2026-09
Sanofi EUR 23.58B 3.56B 2026-06
Xencor USD 170.11M 5.06M 2026-06